May 13, 2016
Gene Therapy for Type 1 Diabetes: Preclinical Promise
Posted by Karen Hurst in category: biotech/medical
For my Precision Medicine partners — nice.
Despite eclectic ways of delivering insulin to control blood glucose level in people with type 1 diabetes (T1D), no approach precisely replicates what happens in the body. Gene therapy may hold the answer.
T1D is usually autoimmune, with inherited risk factors such as certain HLA haplotypes contributing to, but not directly causing, the condition. A clever use of gene therapy is to commandeer liver cells to step in for the pancreatic beta cells that autoimmunity destroys.
Continue reading “Gene Therapy for Type 1 Diabetes: Preclinical Promise” »